Cantel Medical (WKN: 868942) CMN

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products

www.cantelmedical.com/

www.cantelmedical.com/investor/presentations.html

seekingalpha.com/symbol/CMN/focus

financials.morningstar.com/...ment/is.html?t=CMN&ops=clear

de.4-traders.com/CANTEL-MEDICAL-CORP-12112/unternehmen/

www.cantelmedical.com/2q-fy2017-earnings/


Insiderverkauf

www.4-traders.com/...-EVP-Sold-1-500-shares-of-Stock-24190895/

www.cantelmedical.com/about-2/

www.prnewswire.com/news-releases/...0801.html?tc=eml_cleartime

seekingalpha.com/news/...s-13-percent-non-gaap-eps-18-percent

de.4-traders.com/CANTEL-MEDICAL-CORP-12112/

www.marketscreener.com/...scal-4Q-Earnings-Snapshot-27329460/

Jørgen B. Hansen, President and Chief Executive Officer, stated, "We are pleased to report record sales and strong earnings performance this quarter. Our 11.4% reported sales increase was driven by organic growth of 7.5%, the impact from acquisitions of 3.4% and a favorable impact from foreign currency of 0.5%. We continue to perform well internationally where sales were up 30.2% overall, driven by Germany and China. Our U.S. business grew 5.7% in the period.
For the full fiscal year, we reported record sales and earnings performance. Reported sales increased 13.2%, driven by organic growth of 8.4%, the impact from acquisitions of 4.0% and a favorable impact from foreign currency of 0.8%. Internationally the business grew at 33.8% driven by Germany, China and Canada. Our U.S. business grew at 7.4% for the year.

www.marketscreener.com/...-Quarter-Fiscal-Year-2018-27329227/

www.handelsblatt.com/unternehmen/...-GJuesfM9Apa3dWbcm3xs-ap2

www.marketscreener.com/...al-to-Acquire-Omnia-S-p-A-27591774/